Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review
- PMID: 38002582
- PMCID: PMC10672482
- DOI: 10.3390/jcm12226967
Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review
Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, systemic necrotizing vasculitis affecting small-to-medium-sized vessels. EGPA's clinical manifestations are heterogeneous, affecting different organs and systems, and the upper respiratory tract can be affected by ear, nose and throat (ENT) involvement. The aim of our study was to assess type manifestations at the time of diagnosis in a cohort of EGPA patients and correlate findings with baseline variables (sex, age, antineutrophil cytoplasmic antibodies-ANCA-status) and literature reports. The main ENT manifestations in our patients at the time of diagnosis were: chronic rhinosinusitis with nasal polyposis (CRSwNP) (52%), turbinate hypertrophy (48%), nasal swelling (40%), rhinorrhea (40%), chronic rhinosinusitis without nasal polyposis (CRSsNP) (32%), nasal bone deformities (32%), nasal crusts (20%), nasal mucosal ulcers (12%), corditis (12%), hoarseness/dysphonia (12%), hearing loss (12%), mucoceles (4%) and eosinophilic rhinitis (4%). No correlations were found between sex, age, ANCA status and ENT clinical manifestations. A polymorphic ENT involvement is often observed in the early stages of EGPA. The presence of nasal, sinus, ear and/or laryngeal manifestations in patients with asthma and hypereosinophilia, independently of sex, age or ANCA status, should raise an alert for further investigation and differential diagnosis for EGPA. ENT specialists should be aware of their leading position in this diagnostic race.
Keywords: ANCA; CRSwNP; EGPA; ENT; eosinophilic granulomatosis with polyangiitis; hearing loss; otitis; rhinosinusitis; vasculitis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Antineutrophil Cytoplasmic Antibodies and Organ-Specific Manifestations in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis.J Allergy Clin Immunol Pract. 2021 Jan;9(1):445-452.e6. doi: 10.1016/j.jaip.2020.07.038. Epub 2020 Aug 6. J Allergy Clin Immunol Pract. 2021. PMID: 32771687
-
EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).Allergol Select. 2024 Mar 21;8:18-25. doi: 10.5414/ALX02475E. eCollection 2024. Allergol Select. 2024. PMID: 38549809 Free PMC article. Review.
-
A Rare Geriatric Diagnosis of Eosinophilic Granulomatosis With Polyangiitis: A Case Report.Cureus. 2023 Feb 24;15(2):e35398. doi: 10.7759/cureus.35398. eCollection 2023 Feb. Cureus. 2023. PMID: 36846640 Free PMC article.
-
Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.Acta Dermatovenerol Croat. 2022 Sep;30(2):116-118. Acta Dermatovenerol Croat. 2022. PMID: 36254546
-
Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.BMC Pulm Med. 2023 Apr 19;23(1):130. doi: 10.1186/s12890-023-02415-6. BMC Pulm Med. 2023. PMID: 37076824 Free PMC article.
Cited by
-
Overlap or Outlier? Granulomatosis With Polyangiitis With Eosinophilia: A Case Report and Diagnostic Insight.J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251363027. doi: 10.1177/23247096251363027. Epub 2025 Jul 30. J Investig Med High Impact Case Rep. 2025. PMID: 40736995 Free PMC article.
-
Churg-Strauss Syndrome: A Case of Laryngeal Presentation.Laryngoscope. 2025 May;135(5):1771-1773. doi: 10.1002/lary.31935. Epub 2024 Nov 28. Laryngoscope. 2025. PMID: 39605175 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous